Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

1. Rotea-Salvo, S.
2. Martínez-Pradeda, A.
3. Fernández-Oliveira, C.
4. Giménez-Arufe, V.
5. Balboa-Barreiro, V.
6. Margusino-Framiñán, L.
7. Mena-De-Cea, Á.
8. Vázquez-Rodríguez, P.
9. Castro-Iglesias, Á.
10. López-Calvo, S.
11. Martín-Herranz, I.
12. Míguez-Rey, E.
13. Cid-Silva, P.